E.E. Geduld’s Acorda Therapeutics ACOR Stock Holding History

E.E. Geduld’s Portfolio ACOR Stock Details ACOR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-42	Closed	-$214K	–	209
2015 Q4	$214K	Buy	+42	New	+$184K	0.13%	82

Other funds holding ACOR

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

SCM

Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

E.E. Geduld's ACOR Position: Q1 2016 in Review

E.E. Geduld sold out of Acorda Therapeutics (ACOR) in Q1 2016, closing a stake of 42 shares — an estimated $214K sold.

E.E. Geduld first reported a position in ACOR in Q4 2015 and held it in 1 quarter. The position peaked at $214K in Q4 2015. 194 funds tracked by Wall St. Rank hold ACOR as of Q1 2016.

E.E. Geduld reported no remaining Acorda Therapeutics position as of Q1 2016 after selling out during the quarter.
E.E. Geduld sold 42 Acorda Therapeutics shares in Q1 2016, an estimated $214K.
E.E. Geduld first reported a position in Acorda Therapeutics in Q4 2015 and held it in 1 quarter.
E.E. Geduld's Acorda Therapeutics position peaked at $214K in Q4 2015.
194 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q1 2016.

Based on E.E. Geduld's 13F filing for Q1 2016, filed 9 May 2016.